Mureidomycin A, a new inhibitor of bacterial peptidoglycan synthesis.
Mureidomycin A (MRD), a novel peptidylnucleoside antibiotic with antipseudomonal activity, inhibited not only peptidoglycan synthesis but also lipid-intermediate formation from UDP-N-acetylmuramyl (MurNAc)-pentapeptide and UDP-N-acetylglucosamine in an in vitro peptidoglycan-synthesizing system, usi...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1991
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC244983/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1902646/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.2.234 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|